COMMUNIQUÉS West-GlobeNewswire

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2017
11/10/2017
Communiqué de presse Villepinte, le 11 octobre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
ProMIS Neurosciences Provides Third Quarter Update for 2017
11/10/2017
Updated corporate overview available on ProMIS website TORONTO and CAMBRIDGE, Mass., Oct. 11, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of [...]
Auris Medical Announces Share Purchase Agreements with Lincoln Park Capital Fund, LLC
11/10/2017
Zug, Switzerland, October 11, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, announced today [...]
Weifa ASA announces change to its financial calendar
11/10/2017
The quarterly report for Q3 2017 will be published on 30 November 2017, and not on 26 October 2017 as stated in the announcement of 9 December 2016. For further information, please contact: Simen Nyberg-Hansen, CFO of [...]
CellaVision AB presents the third quarter 2017 on October 25 at 11:00 CET
11/10/2017
The information was submitted to the public on October 11, 2017 at 8:20 CET CellaVision will publish the interim report for the third quarter on October 25, 2017 at 08:20 CET. The report will be available at www. [...]
EMISSION PAR GENFIT D'OBLIGATIONS A OPTION DE CONVERSION ET/OU D'ECHANGE EN ACTIONS NOUVELLES ET/OU EXISTANTES (« OCEANE ») A ECHEANCE 2022 POUR UN MONTANT D'ENVIRON 150 MILLIONS D'EUROS
11/10/2017
Ce communiqué ne doit pas être publié, transféré ou diffusé, directement ou indirectement, aux Etats-Unis d'Amérique, au Canada, en Australie ou au Japon. Ce communiqué de presse ne constitue pas une offre de valeurs [...]
GENFIT LAUNCHES AN OFFERING OF BONDS CONVERTIBLE INTO NEW SHARES AND/OR EXCHANGEABLE FOR EXISTING SHARES ("OCEANEs") DUE 2022 FOR AN AMOUNT OF APPROXIMATELY €150 MILLION
11/10/2017
This press release may not be published, forwarded or distributed, directly or indirectly in the United States of America, Canada, Australia or Japan. This press release does not constitute or form part of any offer or [...]
GENFIT : Information financière du troisième trimestre 2017
11/10/2017
GENFIT : Information financière du troisième trimestre 2017 (Données non auditées établies selon les normes IFRS) Trésorerie et équivalents de trésorerie s'élevant à 113,8 millions d'euros au 30 septembre 2017 Chiffre d [...]
GENFIT: Third quarter 2017 financial information
11/10/2017
GENFIT: Third quarter 2017 financial information (Unaudited financial information under IFRS) Cash and cash equivalents of €113.8 million at September 30, 2017 Revenues for the first nine months of 2017 of €91 thousand [...]
Merus to Participate in the BIO Investor Forum
10/10/2017
UTRECHT, The Netherlands, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg [...]
Vistin Pharma ASA : Call for extraordinary general meeting
10/10/2017
Oslo, Norway, 10 October 2017 Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the extraordinary general meeting in Vistin Pharma, to be held on 2 November at 10:00 CET at Østensjøveien 27, Oslo. The [...]
CrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and Diabetes
10/10/2017
SANTA CLARA, Calif., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company [...]
Patient Entrepreneur Finalists Announced for the 2017 Lyfebulb-Novo Nordisk Innovation Summit and Award
10/10/2017
The Summit & Award recognizes and empowers international Patient Entrepreneurs with big ideas that disrupt the future of diabetes management NEW YORK, Oct. 10, 2017 (GLOBE NEWSWIRE) -- The finalists for the 2017 [...]
Abiomed Second Quarter Fiscal 2018 Earnings and Conference Call Notification
10/10/2017
DANVERS, Mass., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ:ABMD) announced that on Thursday, October 26, 2017, the Company will release financial results for the second quarter of fiscal 2018. The Company [...]
Chiffre d'affaires d'Abiomed pour le second trimestre 2018 et notification de conférence téléphonique
10/10/2017
DANVERS, Massachusetts, le 10 octobre 2017 (GLOBE NEWSWIRE) - Abiomed, Inc. (NASDAQ : ABMD) a annoncé qu'elle communiquera ses résultats financiers pour le deuxième trimestre de l'exercice fiscal de 2018 le jeudi 26 [...]
ObsEva SA Announces $60.0 Million Private Placement with Existing and New Investors
10/10/2017
Geneva, Switzerland and Boston, MA - 10 October, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
The IPO of Terveystalo Plc has been oversubscribed and the listing will be completed as planned
10/10/2017
TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 10, 2017 at 3:00 p.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]
Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections
10/10/2017
Arix Bioscience notes positive Phase I clinical and non-clinical data from Amplyx for the treatment of life-threatening fungal infections LONDON, 10 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a [...]
Apricus Biosciences to Present at the 2017 BIO Investor Forum
10/10/2017
SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief [...]

Pages